<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1490">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01909700</url>
  </required_header>
  <id_info>
    <org_study_id>2011041</org_study_id>
    <nct_id>NCT01909700</nct_id>
  </id_info>
  <brief_title>Single Incision Pelvic Floor Mesh Implants</brief_title>
  <official_title>Single Incision Pelvic Floor Mesh Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western Galilee Hospital-Nahariya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western Galilee Hospital-Nahariya</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives: To evaluate whether the use of single incision un-anchored small mesh implants
      is feasible, safe and effective for women with moderate pelvic organ prolapse.

      Design: Patients diagnosed with moderate pelvic organ prolapse were enrolled to undergo a
      single incision un-anchored mesh operation. Follow-up was 4 to 23 months. The outcome
      measures for this study were the operative safety and post-operative pain, adverse effects
      and anatomical as well as functional cure.

      Setting: The operations were performed under general anesthesia according with the reported
      surgical techniques at university and private hospitals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligibility criteria: female patients with moderate pelvic organ prolapse Outcome measures:
      intra operative safety and surgical complications, post operative complications and
      objective as well as subjective cure rates
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Operative mesh related complications</measure>
    <time_frame>12 Monthes</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">157</enrollment>
  <condition>Intra-operative Complications</condition>
  <condition>Post Operative Complications</condition>
  <arm_group>
    <arm_group_label>Single Incision Meshe</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intervention: single incision mesh implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single Incision Mesh</intervention_name>
    <description>Single Incision Mesh is implanted for pelvic floor reconstruction</description>
    <arm_group_label>Single Incision Meshe</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single Incision Mesh</intervention_name>
    <description>Single Incision Mesh is implanted</description>
    <arm_group_label>Single Incision Meshe</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients with Gr 2-3 Pelvic Organ Prolapse -

        Exclusion Criteria: Previous Pelvic irradiation

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Menahem Neuman, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western Galilee MC Nahariya</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assuta MC</name>
      <address>
        <city>Tel Aviv</city>
        <zip>45320</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 24, 2013</lastchanged_date>
  <firstreceived_date>July 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Single Incision, Mesh, Complications</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Intraoperative Complications</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
